<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37464326</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Neutralizing activity of intravenous immune globulin products against enterovirus D68 strains isolated in Japan.</ArticleTitle><Pagination><StartPage>481</StartPage><MedlinePgn>481</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">481</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08429-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enterovirus D68 (EV-D68), belonging to Enterovirus D, is a unique human enterovirus mainly associated with common respiratory diseases. However, EV-D68 can cause severe respiratory diseases, and EV-D68 endemic is epidemiologically linked to current global epidemic of acute flaccid myelitis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we measured neutralizing antibody titers against six clinical EV-D68 isolates in nine intravenous immune globulin (IVIG) products commercially available in Japan to assess their potential as therapeutic options for severe EV-D68 infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven IVIG products manufactured from Japanese donors contained high neutralizing antibody titers (IC<sub>50</sub> = 0.22-85.01 µg/mL) against all six EV-D68 strains. Apparent differences in neutralizing titers among the six EV-D68 strains were observed for all IVIG products derived from Japanese and non-Japanese blood donors.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">High levels of EV-D68-neutralizing antibodies in IVIG products manufactured from Japanese donors suggest that anti-EV-D68 antibodies are maintained in the Japanese donor population similarly as found in foreign blood donors. Apparent differences in neutralizing antibody titers against the six EV-D68 strains suggest distinct antigenicity among the strains used in this study regardless of the genetic similarity of EV-D68.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Kazuhiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Virology 2, National Institute of Infectious Diseases, Tokyo, Japan. 6yoshida12@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muramatsu</LastName><ForeName>Masamichi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology 2, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease Research, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Virology 2, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>H28-Shinkogyosei-Ippan-007</GrantID><Agency>the Ministry of Health, Labour and Welfare of Japan</Agency><Country /></Grant><Grant><GrantID>19fk0108084j0001</GrantID><Agency>the Japan Agency for Medical Research and Development</Agency><Country /></Grant><Grant><GrantID>19H03626</GrantID><Agency>the Ministry of Education, Culture, Sports, Science, and Technology in Japan</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus D68</Keyword><Keyword MajorTopicYN="N">IVIG</Keyword><Keyword MajorTopicYN="N">Japan</Keyword><Keyword MajorTopicYN="N">Neutralization activity</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>18</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37464326</ArticleId><ArticleId IdType="pmc">PMC10394975</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08429-z</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08429-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16:368–81. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieble JH, Fox VL, Lennette EH. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol. 1967;85:297–310. doi: 10.1093/oxfordjournals.aje.a120693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120693</ArticleId><ArticleId IdType="pubmed">4960233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Hu XY, Yu XF. Current understanding of human enterovirus D68. Viruses. 2019;11:E490. doi: 10.3390/v11060490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11060490</ArticleId><ArticleId IdType="pmc">PMC6631698</ArticleId><ArticleId IdType="pubmed">31146373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Frost J, Rudy MJ, Messacar K, Clarke P, Tyler KL. Understanding enterovirus D68-induced neurologic disease: a basic science review. Viruses. 2019;11:E821. doi: 10.3390/v11090821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11090821</ArticleId><ArticleId IdType="pmc">PMC6783995</ArticleId><ArticleId IdType="pubmed">31487952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda T, Mizuta K, Abiko C, Aoki Y, Itagaki T, Katsushima F, et al. Acute respiratory infections due to enterovirus 68 in Yamagata, Japan between 2005 and 2010. Microbiol Immunol. 2012;56:139–43. doi: 10.1111/j.1348-0421.2012.00411.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2012.00411.x</ArticleId><ArticleId IdType="pubmed">22309616</ArticleId></ArticleIdList></Reference><Reference><Citation>Itagaki T, Aoki Y, Matoba Y, Tanaka S, Ikeda T, Mizuta K, Matsuzaki Y. Clinical characteristics of children infected with enterovirus D68 in an outpatient clinic and the association with bronchial asthma. Infect Dis (Lond) 2018;50:303–312. https://www.tandfonline.com/doi/full/10.1080/23744235.2017.1400176?needAccess=true.</Citation><ArticleIdList><ArticleId IdType="pubmed">29119851</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Asturias EJ, Hixon AM, Van Leer-Buter CV, Niesters HGM, Tyler KL, et al. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Lancet Infect Dis. 2018;18:e239–47. doi: 10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Folkers GK, Fauci AS. Acute flaccid myelitis: something old and something new. mBio. 2019;10:e00521–19. doi: 10.1128/mBio.00521-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00521-19</ArticleId><ArticleId IdType="pmc">PMC6445942</ArticleId><ArticleId IdType="pubmed">30940708</ArticleId></ArticleIdList></Reference><Reference><Citation>Helfferich J, Knoester M, Van Leer-Buter CCV, Neuteboom RF, Meiners LC, Niesters HG, Brouwer OF. Acute flaccid myelitis and enterovirus D68: Lessons from the past and present. Eur J Pediatr. 2019;178:1305–15. doi: 10.1007/s00431-019-03435-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-019-03435-3</ArticleId><ArticleId IdType="pmc">PMC6694036</ArticleId><ArticleId IdType="pubmed">31338675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer R, Lina B, Shetty J. Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice. Eur J Paediatr Neurol 2019;23:235–239. https://www.ejpn-journal.com/article/S1090-3798(18)30281-2/fulltext</Citation><ArticleIdList><ArticleId IdType="pubmed">30670331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra N, Ng TFF, Marine RL, Jain K, Ng J, Thakkar R, et al. Antibodies to enteroviruses in cerebrospinal fluid of patients with acute flaccid myelitis. mBio. 2019;10:e01903–19. doi: 10.1128/mBio.01903-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01903-19</ArticleId><ArticleId IdType="pmc">PMC6692520</ArticleId><ArticleId IdType="pubmed">31409689</ArticleId></ArticleIdList></Reference><Reference><Citation>Okumura A, Mori H, Fee Chong PF, Kira R, Torisu H, Yasumoto S et al. Serial MRI findings of acute flaccid myelitis during an outbreak of enterovirus D68 infection in Japan. Brain Dev 2019;41:443–451. https://www.brainanddevelopment.com/article/S0387-7604(18)30496-0/fulltext</Citation><ArticleIdList><ArticleId IdType="pubmed">30594353</ArticleId></ArticleIdList></Reference><Reference><Citation>Division of Viral Diseases, National Centers for Immunization and Respiratory. Diseases CDC. Division of Vector-borne Diseases, Division of high-consequence Pathogens and Pathology, National Center for emerging and zoonotic infectious Diseases, CDC. Children’s Hospital Colorado; Council of State and Territorial Epidemiologists. Notes from the field: Acute flaccid myelitis among persons aged ≦ 21 years–United States, August 1 - November 13, 2014. MMWR Morb Mortal Wkly Rep. 2015;63:1243–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646045</ArticleId><ArticleId IdType="pubmed">25577990</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliabadi N, Messacar K, Pastula DM, Robinson CC, Leshem E, Sejvar JJ, et al. Enterovirus D68 infection in children with acute flaccid myelitis, Colorado, USA, 2014. Emerg Infect Dis. 2016;22:1387–94. doi: 10.3201/eid2208.151949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2208.151949</ArticleId><ArticleId IdType="pmc">PMC4982171</ArticleId><ArticleId IdType="pubmed">27434186</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller L, et al. Acute flaccid myelitis in the United States, August-December 2014: results of nationwide surveillance. Clin Infect Dis. 2016;63:737–45. doi: 10.1093/cid/ciw372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw372</ArticleId><ArticleId IdType="pmc">PMC5709818</ArticleId><ArticleId IdType="pubmed">27318332</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Centers for Disease Control and Prevention. Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ. 2006;55:1–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: A systematic review. Lancet Infect Dis 2016;16:e64-e75. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(15)00543-5/fulltext.</Citation><ArticleIdList><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Abzug MJ, Dominguez SR. The emergence of enterovirus-D68. Microbiol Spectr. 2016;4. 10.1128/microbiolspec.EI10-0018-2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27337448</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastula DM, Aliabadi N, Haynes AK, Messacar K, Schreiner T, Maloney J, et al. Acute neurologic illness of unknown etiology in children–Colorado, August-September 2014. MMWR Morb Mortal Wkly Rep. 2014;63:901–2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584613</ArticleId><ArticleId IdType="pubmed">25299607</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Jackson MA, Selvarangan R, Turabelidze G, Obringer E, Johnson D, et al. Severe respiratory illness associated with enterovirus D68–Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:798–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584696</ArticleId><ArticleId IdType="pubmed">25211545</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Enterovirus D68. https://www.cdc.gov/non-polio-enterovirus/about/EV-D68.html. Accessed 17 February 2023.</Citation></Reference><Reference><Citation>Chong PF, Kira R, Mori H, Okumura A, Torisu H, Yasumoto S, et al. Clinical features of acute flaccid myelitis temporally associated with an Enteerovirus D68 outbreak: results of a nationwide survey of acute flaccid paralysis in Japan, August-December 2015. Clin Infect Dis. 2018;66:653–64. doi: 10.1093/cid/cix860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix860</ArticleId><ArticleId IdType="pmc">PMC5850449</ArticleId><ArticleId IdType="pubmed">29028962</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi Y, Ito K, Morino S, Kinoshita K, Morikawa Y, Kono T, et al. Enterovirus D68 respiratory infection in a children’s hospital in Japan in 2015. Pediatr Int. 2019;61:768–76. doi: 10.1111/ped.13903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.13903</ArticleId><ArticleId IdType="pmc">PMC7167638</ArticleId><ArticleId IdType="pubmed">31136073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaida A, Iritani N, Yamamoto SP, Kanbayashi D, Hirai Y, Togawa M, et al. Distinct genetic clades of enterovirus D68 detected in 2010, 2013, and 2015 in Osaka City, Japan. PLoS ONE. 2017;12:e0184335. doi: 10.1371/journal.pone.0184335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184335</ArticleId><ArticleId IdType="pmc">PMC5597212</ArticleId><ArticleId IdType="pubmed">28902862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikuse T, Aizawa Y, Yamanaka T, Habuka R, Watanabe K, Otsuka T, Saitoh A. Outbreak of enterovirus D68 among children in Japan-worldwide circulation of enterovirus D68 clade B3 in 2018. Pediatr Infect Dis J. 2021;40:6–10. doi: 10.1097/INF.0000000000002889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002889</ArticleId><ArticleId IdType="pubmed">32947598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Moore DD, Nix WA, Oberste MS, Weldon WC. Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products. J Clin Virol. 2015;69:172–5. doi: 10.1016/j.jcv.2015.06.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.06.086</ArticleId><ArticleId IdType="pmc">PMC6512324</ArticleId><ArticleId IdType="pubmed">26209401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Clarke P, Tyler KL. Evaluating treatment efficacy in a mouse model of enterovirus D68-associated paralytic myelitis. J Infect Dis. 2017;216:1245–53. doi: 10.1093/infdis/jix468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix468</ArticleId><ArticleId IdType="pmc">PMC5853295</ArticleId><ArticleId IdType="pubmed">28968718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudy MJ, Frost J, Clarke P, Tyler KL. Neutralizing antibody given after paralysis onset reduces the severity of paralysis compared to nonspecific antibody-treated controls in a mouse model of EV-D68-Associated acute flaccid myelitis. Antimicrob Agents Chemother. 2022;66:e0022722. doi: 10.1128/aac.00227-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.00227-22</ArticleId><ArticleId IdType="pmc">PMC9380545</ArticleId><ArticleId IdType="pubmed">35894595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kärber G. Beitrag zur Kollektiven Behandlung pharmakologischer Reihenversuche. Archiv f experiment Pathol u Pharmakol. 1931;162:480–3. doi: 10.1007/BF01863914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01863914</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa Y, Watanabe K, Oishi T, Hirano H, Hasegawa I, Saitoh A. Role of maternal antibodies in infants with severe diseases related to human parechovirus type 3. Emerg Infect Dis. 2015;21:1966–72. doi: 10.3201/eid2111.150267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2111.150267</ArticleId><ArticleId IdType="pmc">PMC4622238</ArticleId><ArticleId IdType="pubmed">26485714</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T, Okamoto M, Nakakita S, Suzuki A, Saito M, Tamaki R, et al. Antigenic and receptor binding properties of enterovirus 68. J Virol. 2014;88:2374–84. doi: 10.1128/JVI.03070-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03070-13</ArticleId><ArticleId IdType="pmc">PMC3958110</ArticleId><ArticleId IdType="pubmed">24371050</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidor E. Poliovirus vaccine-inactivated. In: Plotkin SA, Orenstein W, Offit PA, Edwards KM. Vaccines E-book, 7th edition. Elsevier Health Sciences; 2018. p. 94685–94689 (Kindle version). https://www.elsevier.com/books/plotkins-vaccines/9780323357616</Citation></Reference><Reference><Citation>Liu L, Mo Z, Liang Z, Zhang Y, Li R, Ong KC, et al. Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy chinese children: a report of further observations. BMC Med. 2015;13:226. doi: 10.1186/s12916-015-0448-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0448-7</ArticleId><ArticleId IdType="pmc">PMC4574357</ArticleId><ArticleId IdType="pubmed">26381232</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt MR, Crowe JE., Jr Current understanding of humoral immunity to enterovirus D68. J Pediatr Infect Dis Soc. 2018;7(Supplement 2):49–S53. doi: 10.1093/jpids/piy124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piy124</ArticleId><ArticleId IdType="pubmed">30590621</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, et al. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med. 2019;25:1748–52. doi: 10.1038/s41591-019-0613-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0613-1</ArticleId><ArticleId IdType="pmc">PMC6858576</ArticleId><ArticleId IdType="pubmed">31636453</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med. 2021;13:eabd2400. doi: 10.1126/scitranslmed.abd2400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd2400</ArticleId><ArticleId IdType="pubmed">33692131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd S, Lopez AS, Konopka-Anstadt JL, Nix WA, Routh JA, Oberste MS. Enterovirus D68-associated acute flaccid myelitis, United States, 2020. Emerg Infect Dis. 2020;26:e201630. doi: 10.3201/eid2610.201630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2610.201630</ArticleId><ArticleId IdType="pmc">PMC7510737</ArticleId><ArticleId IdType="pubmed">32833616</ArticleId></ArticleIdList></Reference><Reference><Citation>Carballo CM, Erro MG, Sordelli N, Vazquez G, Mistchenko AS, Cejas C, et al. Acute flaccid myelitis associated with enterovirus D68 in children, Argentina, 2016. Emerg Infect Dis. 2019;25:573–6. doi: 10.3201/eid2503.170897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2503.170897</ArticleId><ArticleId IdType="pmc">PMC6390768</ArticleId><ArticleId IdType="pubmed">30602120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong L, Wang Y, Zhang W, Chen C, Yang X, Xu L, et al. Acute flaccid myelitis in children in Zhejiang Province, China. Front Neurol. 2020;11:360. doi: 10.3389/fneur.2020.00360/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00360/full</ArticleId><ArticleId IdType="pmc">PMC7256184</ArticleId><ArticleId IdType="pubmed">32528396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrinelli L, Galli C, Primache V, Bubba L, Buttinelli G, Stefanelli P et al. Emerging Non-Polio enteroviruses recognized in the framework of the Acute Flaccid Paralyses (AFP) surveillance system in Northern Italy, 2016–2018. Int J Infect Dis 2021;106:36–40. https://www.ijidonline.com/article/S1201-9712(21)00275-7/fulltext.</Citation><ArticleIdList><ArticleId IdType="pubmed">33771675</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt MR, Fu J, Kose N, Williamson LE, Bombardi R, Setliff I, et al. Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease. Sci Immunol. 2020;5:eaba4902. doi: 10.1126/sciimmunol.aba4902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aba4902</ArticleId><ArticleId IdType="pmc">PMC7418079</ArticleId><ArticleId IdType="pubmed">32620559</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison CJ, Weldon WC, Pahud BA, Jackson MA, Oberste MS, Selvarangan R. Neutralizing antibody against enterovirus D68 in children and adults before 2014 outbreak, Kansas City, Missouri, USA1. Emerg Infect Dis. 2019;25:585–8. doi: 10.3201/eid2503.180960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2503.180960</ArticleId><ArticleId IdType="pmc">PMC6390745</ArticleId><ArticleId IdType="pubmed">30789123</ArticleId></ArticleIdList></Reference><Reference><Citation>Karelehto E, Koen G, Benschop K, van der Klis F, Pajkrt D, Wolthers K. Enterovirus D68 serosurvey: Evidence for endemic circulation in the Netherlands, 2006 to 2016. Euro Surveill 2019;24:1800671. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.35.1800671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6724466</ArticleId><ArticleId IdType="pubmed">31481149</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li L, Ren L, Guo L, Xie Z, Liu C, et al. Seroepidemiology of enterovirus D68 infection in China. Emerg Microbes Infect. 2017;6:e32. doi: 10.1038/emi.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.14</ArticleId><ArticleId IdType="pmc">PMC5520479</ArticleId><ArticleId IdType="pubmed">28487560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S-Y, Gao F, Hu Y-L, Bian L-L, Mao Q-Y, Wu X. Seroepidemiology of enterovirus D68 infection in infants and children in Jiangsu, China. J Infect 2018;76:563–569. https://www.journalofinfection.com/article/S0163-4453(18)30055-0/fulltext.</Citation><ArticleIdList><ArticleId IdType="pubmed">29428227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YF, Sam IC, Nayan E, Tan XH, Yogarajah T. Seroepidemiology of enterovirus D68 infection in Kuala Lumpur, Malaysia between 2013 and 2015. J Med Virol. 2022;94:2607–12. doi: 10.1002/jmv.27381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27381</ArticleId><ArticleId IdType="pubmed">34617599</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JT, Shih WL, Yen TY, Cheng AL, Lu CY, Chang LY, Huang LM. Enterovirus D68 seroepidemiology in Taiwan, a cross sectional study from 2017. PLoS ONE. 2020;15:e0230180. doi: 10.1371/journal.pone.0230180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230180</ArticleId><ArticleId IdType="pmc">PMC7064212</ArticleId><ArticleId IdType="pubmed">32155216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>